During the past decade, Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Ipsen" with 3 trials sponsored, "Chiasma, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are "Acromegaly" (4 trials), "HIV Infections" (4 trials), "Rheumatoid Arthritis" (3 trials), "Giant Cell Arteritis" (1 trials) and "Hyperaldosteronism" (1 trials). Many other conditions were trialed in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" in a lesser frequency.

Most popular intervention types in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are "Drug" (14 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Tocilizumab" (4 trials), "Methotrexate" (3 trials), "Placebo" (2 trials), "Prednisone" (2 trials) and "Corticosteroids" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum der Universität München; Bereich Pettenkoferstr.; Rheumaeinheit der medizinischen Klinik IV, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".